Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium 2019, 'Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma' Chest, bind 156, nr. 6, s. 1068-1079. https://doi.org/10.1016/j.chest.2019.08.2202

APA

CBE

MLA

Vancouver

Author

NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium. / Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma. I: Chest. 2019 ; Bind 156, Nr. 6. s. 1068-1079.

Bibtex

@article{addb2d50946d401f924e82f8cda94068,
title = "Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma",
abstract = "Background: Asthma is a common respiratory disorder with a highly heterogeneous nature that remains poorly understood. The objective was to use whole genome sequencing (WGS) data to identify regions of common genetic variation contributing to lung function in individuals with a diagnosis of asthma. Methods: WGS data were generated for 1,053 individuals from trios and extended pedigrees participating in the family-based Genetic Epidemiology of Asthma in Costa Rica study. Asthma affection status was defined through a physician's diagnosis of asthma, and most participants with asthma also had airway hyperresponsiveness (AHR) to methacholine. Family-based association tests for single variants were performed to assess the associations with lung function phenotypes. Results: A genome-wide significant association was identified between baseline FEV 1/FVC ratio and a single-nucleotide polymorphism in the top hit cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2) (rs12051168; P = 3.6 × 10 −8 in the unadjusted model) that retained suggestive significance in the covariate-adjusted model (P = 5.6 × 10 −6). Rs12051168 was also nominally associated with other related phenotypes: baseline FEV 1 (P = 3.3 × 10 −3), postbronchodilator (PB) FEV 1 (7.3 × 10 −3), and PB FEV 1/FVC ratio (P = 2.7 × 10 −3). The identified baseline FEV 1/FVC ratio and rs12051168 association was meta-analyzed and replicated in three independent cohorts in which most participants with asthma also had confirmed AHR (combined weighted z-score P =.015) but not in cohorts without information about AHR. Conclusions: These findings suggest that using specific asthma characteristics, such as AHR, can help identify more genetically homogeneous asthma subgroups with genotype-phenotype associations that may not be observed in all children with asthma. CRISPLD2 also may be important for baseline lung function in individuals with asthma who also may have AHR.",
keywords = "airway hyperresponsiveness, asthma, lung function, whole genome sequencing",
author = "Priyadarshini Kachroo and Julian Hecker and Bo Chawes and Ahluwalia, {Tarunveer S} and Michael Cho and Dandi Qiao and Kelly, {Rachel S} and Chu, {Su H} and Virkud, {Yamini V} and Mengna Huang and Barnes, {Kathleen C} and Burchard, {Esteban G} and Celeste Eng and Donglei Hu and Celed{\'o}n, {Juan C} and Michelle Daya and Levin, {Albert M} and Hongsheng Gui and Williams, {L Keoki} and Erick Forno and Mak, {Angel C Y} and Lydiana Avila and Manuel Soto-Quiros and Cloutier, {Michelle M} and Edna Acosta-P{\'e}rez and Glorisa Canino and Klaus B{\o}nnelykke and Hans Bisgaard and Raby, {Benjamin A} and Christoph Lange and Weiss, {Scott T} and Jessica Lasky-Su and {NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium}",
note = "Copyright {\circledC} 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.",
year = "2019",
month = "12",
doi = "10.1016/j.chest.2019.08.2202",
language = "English",
volume = "156",
pages = "1068--1079",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

RIS

TY - JOUR

T1 - Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma

AU - Kachroo, Priyadarshini

AU - Hecker, Julian

AU - Chawes, Bo

AU - Ahluwalia, Tarunveer S

AU - Cho, Michael

AU - Qiao, Dandi

AU - Kelly, Rachel S

AU - Chu, Su H

AU - Virkud, Yamini V

AU - Huang, Mengna

AU - Barnes, Kathleen C

AU - Burchard, Esteban G

AU - Eng, Celeste

AU - Hu, Donglei

AU - Celedón, Juan C

AU - Daya, Michelle

AU - Levin, Albert M

AU - Gui, Hongsheng

AU - Williams, L Keoki

AU - Forno, Erick

AU - Mak, Angel C Y

AU - Avila, Lydiana

AU - Soto-Quiros, Manuel

AU - Cloutier, Michelle M

AU - Acosta-Pérez, Edna

AU - Canino, Glorisa

AU - Bønnelykke, Klaus

AU - Bisgaard, Hans

AU - Raby, Benjamin A

AU - Lange, Christoph

AU - Weiss, Scott T

AU - Lasky-Su, Jessica

AU - NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium

N1 - Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

PY - 2019/12

Y1 - 2019/12

N2 - Background: Asthma is a common respiratory disorder with a highly heterogeneous nature that remains poorly understood. The objective was to use whole genome sequencing (WGS) data to identify regions of common genetic variation contributing to lung function in individuals with a diagnosis of asthma. Methods: WGS data were generated for 1,053 individuals from trios and extended pedigrees participating in the family-based Genetic Epidemiology of Asthma in Costa Rica study. Asthma affection status was defined through a physician's diagnosis of asthma, and most participants with asthma also had airway hyperresponsiveness (AHR) to methacholine. Family-based association tests for single variants were performed to assess the associations with lung function phenotypes. Results: A genome-wide significant association was identified between baseline FEV 1/FVC ratio and a single-nucleotide polymorphism in the top hit cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2) (rs12051168; P = 3.6 × 10 −8 in the unadjusted model) that retained suggestive significance in the covariate-adjusted model (P = 5.6 × 10 −6). Rs12051168 was also nominally associated with other related phenotypes: baseline FEV 1 (P = 3.3 × 10 −3), postbronchodilator (PB) FEV 1 (7.3 × 10 −3), and PB FEV 1/FVC ratio (P = 2.7 × 10 −3). The identified baseline FEV 1/FVC ratio and rs12051168 association was meta-analyzed and replicated in three independent cohorts in which most participants with asthma also had confirmed AHR (combined weighted z-score P =.015) but not in cohorts without information about AHR. Conclusions: These findings suggest that using specific asthma characteristics, such as AHR, can help identify more genetically homogeneous asthma subgroups with genotype-phenotype associations that may not be observed in all children with asthma. CRISPLD2 also may be important for baseline lung function in individuals with asthma who also may have AHR.

AB - Background: Asthma is a common respiratory disorder with a highly heterogeneous nature that remains poorly understood. The objective was to use whole genome sequencing (WGS) data to identify regions of common genetic variation contributing to lung function in individuals with a diagnosis of asthma. Methods: WGS data were generated for 1,053 individuals from trios and extended pedigrees participating in the family-based Genetic Epidemiology of Asthma in Costa Rica study. Asthma affection status was defined through a physician's diagnosis of asthma, and most participants with asthma also had airway hyperresponsiveness (AHR) to methacholine. Family-based association tests for single variants were performed to assess the associations with lung function phenotypes. Results: A genome-wide significant association was identified between baseline FEV 1/FVC ratio and a single-nucleotide polymorphism in the top hit cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2) (rs12051168; P = 3.6 × 10 −8 in the unadjusted model) that retained suggestive significance in the covariate-adjusted model (P = 5.6 × 10 −6). Rs12051168 was also nominally associated with other related phenotypes: baseline FEV 1 (P = 3.3 × 10 −3), postbronchodilator (PB) FEV 1 (7.3 × 10 −3), and PB FEV 1/FVC ratio (P = 2.7 × 10 −3). The identified baseline FEV 1/FVC ratio and rs12051168 association was meta-analyzed and replicated in three independent cohorts in which most participants with asthma also had confirmed AHR (combined weighted z-score P =.015) but not in cohorts without information about AHR. Conclusions: These findings suggest that using specific asthma characteristics, such as AHR, can help identify more genetically homogeneous asthma subgroups with genotype-phenotype associations that may not be observed in all children with asthma. CRISPLD2 also may be important for baseline lung function in individuals with asthma who also may have AHR.

KW - airway hyperresponsiveness

KW - asthma

KW - lung function

KW - whole genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=85075322046&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2019.08.2202

DO - 10.1016/j.chest.2019.08.2202

M3 - Journal article

VL - 156

SP - 1068

EP - 1079

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -

ID: 58132646